This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Research » Trials

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Novartis’s Diabetes Drug Galvus Will Be Delayed

Posted: Wednesday, November 22, 2006

A U.S. decision on approving Novartis AG's key diabetes drug Galvus has been delayed by three months after the firm asked the Food and Drug Administration to consider new clinical trials data.

Artificial Pancreas Testing to Begin Jan. 2007

Posted: Thursday, November 16, 2006

A team of scientists in Britain are in the process starting the first study of a closed loop system with 12 children with Type 1 diabetes. The device if successful promises to transform the lives of scores of youngsters.

Acomplia ™(Rimonabant) Receives 1st Marketing Authorization in North America

Posted: Thursday, November 16, 2006

Acomplia™ (rimonabant) approved in Mexico to treat obese/overweight patients with associated type 2 diabetes or dyslipidemia or to help them improve glycemic control on background of conventional antidiabetic treatment.

Importance of Fasting Hyperglycemia Dependent on HbA1c

Posted: Thursday, November 09, 2006

Study concluded that the contribution of fasting hyperglycemia was greater in patients with increased HbA1c.

Diet Drug Acomplia Seen Needing More Testing as Diabetes Treatment

Posted: Thursday, November 02, 2006

Sanofi's highly anticipated diet drug Acomplia (rimonabant) may also be useful in helping obese diabetics control their blood sugar levels, but some respected researchers have expressed skepticism and called for additional testing in the prestigious British medical journal Lancet.

Pramlintide Continues Trials for Weight Loss

Posted: Thursday, November 02, 2006

Results of a Phase 2 study show a 8% reduction in weight. Pramlintide shows weight loss for those even without diabetes.

New Magic Weight-Loss Pill rimonabant (Acomplia) Offers Modest Results, Blocks 'Munchies'

Posted: Wednesday, October 25, 2006

A new drug billed as a magic bullet for obesity — rimonabant (Acomplia) — does help people lose weight, although not that much weight, and also helps lower cardiac risk factors, according to a review of studies.

Study: Leptin Has Powerful Effect on Reward Center in the Brain

Posted: Wednesday, October 25, 2006

Leptin, a hormone critical for normal food intake and metabolism, exerts a strong effect on appetite by acting in the mid-brain region as well as in the hypothalamus, according to a Yale School of Medicine study in Neuron.

Study: Genes and Diet Linked to Risk Factors for Heart Disease

Posted: Wednesday, October 25, 2006

Researchers from the Jean Mayer USDA Human Nutrition Research Center (USDA HNRCA) at Tufts University and colleagues have found another link among genes, heart disease and diet.

Ramipril of Limited Benefit in Preventing Diabetes, But………..

Posted: Thursday, October 19, 2006

However, ramipril may improve glucose metabolism by promoting regression to normal blood sugar levels or "normoglycemia."